Press Releases
-
KCR opens new branch in Sydney, Australia
KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.
Feb 24, 2021
-
Alfa Chemistry Materials Offers Battery Materials to Produce Organic and Printed Electronics
-
Saama Teams with Oracle to Offer Life Sciences Industry AI-Enabled Applications to Accelerate Clinical Trials
Saama and Oracle collaborate to bring game-changing, AI-powered smart applications to the Life Sciences industry to speed clinical development
Feb 28, 2021
-
Quinten spins off 50 data scientists to become a global leader in precision care using artificial intelligence and real-world data science
Quinten, a pioneer in AI-powered decision support solutions, has launched Quinten Health — a global and integrated analytical services and tools development offer.
Feb 28, 2021
-
Europital board forewarns that clinical deficits to slow biotech development in 2021
-
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
-
Thermo Fisher Scientific Analytical Instruments Receive Prominent Industry Awards
Thermo Fisher Scientific’s latest announcement that its analytical instruments have been recognized through multiple respected industry awards.
Feb 15, 2021
-
Medivir licenses preclinical USP7 program to Ubiquigent
Ubiquigent announces it has entered an exclusive license agreement with Medivir AB to access their preclinical USP7 research program.
Feb 15, 2021
-
Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
Biocept presents data showing that its Target Selector™ molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS), at the Molecular Med Tri-Con Virtual Conference.
Feb 15, 2021
-
MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry
-
Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation
-
ObvioHealth Announces Next Generation Virtual Research Platform and Ecosystem
-
VivaLNK Offers Untethered Wearable ECG Monitor Solution for Six-Minute Walk Test
Captures ECG and heart rate as a response to treatment for heart, lung, and health problems
Feb 15, 2021
-
Profacgen Updated Its Service for Isothermal Titration Calorimetry
-
Whole Genome Sequencing for GutFlora Now Available by the GutFlora Omics Platform
The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.
Feb 22, 2021
-
Pronalyse Division Supports Biopharma Research with Protein Homogeneity Analysis Service
Pronalyse, a new division of Creative Proteomics, is dedicated to providing professional analysis services in biopharmaceutical development. Creative Proteomics is an integrated CRO company with more than 10 years of experience in providing impurity analysis and analytical characterization service for bioprocess development. Recently, the product manager of Pronalyse division announced protein homogeneity analysis service to speed up the drug development process.
Feb 22, 2021
-
UK Healthcare Pavilion brings Together the UK’s Healthcare and Life Sciences Sector for The First Time
The UK Healthcare Pavilion has launched a new virtual platform to bring together life sciences companies, hospitals, clinics, and key organisations — helping global customers discover, connect and innovate.
Feb 22, 2021
-
CD BioSciences Announces to Provide Global Scientists with Early Phase Clinical Services
CD BioSciences, a US based supplier of clinical development services, has announced to provide global scientists with early phase clinical services, aiming to accelerate their drug development projects.
Feb 23, 2021
-
VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine
-
BOC Sciences Launched Its E3 Ubiquitin Ligase Activity Assay Services to Assist PROTAC Drug Development